Verrica Pharmaceuticals Inc. VRCA
3.50 USD +0.21 (+6.38%)
Nov 4, 2026, 2:25 PM EST
3.36 Day range 3.50
3.20 52-week range 9.82
- YTD
- -57.88%
- 1 year
- +6.71%
Analyst view
Consensus: buy
Buy
Price target (mean) 6.33 +81.0% upside
Now 3.50
- Target (low)
- 2.00
- Target (mean)
- 6.33
- Target (high)
- 12.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.284 | -0.42 – -0.19 | -0.53 | +46.4% | 710.33K | -64.3% | 5 |
| Next quarter | -0.195 | -0.30 – -0.09 | -0.44 | +55.7% | 2.11M | -44.9% | 2 |
| Current year | -1.46 | -1.71 – -1.27 | -1.48 | +1.1% | 7.74M | +51.1% | 5 |
| Next year | -0.5525 | -0.95 – -0.25 | -1.46 | +62.3% | 14.75M | +90.4% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Needham | Reiterated | Hold | Hold |
| Nov 6, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Nov 5, 2024 | Needham | Reiterated | — | Hold |
| Nov 5, 2024 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Oct 21, 2024 | TD Cowen | Maintained | Buy | Buy |
| Oct 4, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 3, 2024 | Needham | Downgrade | Buy | Hold |
| Oct 2, 2024 | Brookline Capital | Downgrade | Buy | Hold |
| Aug 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 15, 2024 | Needham | Maintained | Buy | Buy |
| May 16, 2024 | Needham | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 14, 2024 | Needham | Maintained | Buy | Buy |
| Apr 10, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 1, 2024 | Needham | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 15, 2023 | Jefferies | Reiterated | Buy | Buy |
| Nov 10, 2023 | Needham | Maintained | Buy | Buy |
| Oct 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 23, 2023 | Needham | Reiterated | Buy | Buy |
| Aug 10, 2023 | Needham | Reiterated | Buy | Buy |
| Jul 27, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 25, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 25, 2023 | Needham | Upgrade | Hold | Buy |
| Jul 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 22, 2023 | Jefferies | Initiated | — | Buy |
| Mar 7, 2023 | RBC Capital | Reiterated | — | Outperform |
| Feb 13, 2023 | RBC Capital | Upgrade | Sector Perform | Outperform |
| May 31, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 25, 2022 | RBC Capital | Downgrade | Outperform | Sector Perform |